JP Morgan Maintains Overweight on Erasca, Raises Price Target to $25

JP Morgan analyst Anupam Rama has maintained an Overweight rating on Erasca (NASDAQ: ERAS) and raised the price target from $24 to $25. This adjustment reflects a positive outlook on the company's performance.